ProShare Advisors LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$241,610
-18.1%
5,323
+1.3%
0.00%0.0%
Q2 2023$294,959
+12.2%
5,254
-9.6%
0.00%0.0%
Q1 2023$262,786
-15.6%
5,810
-24.2%
0.00%0.0%
Q4 2022$311,501
-38.9%
7,663
-1.8%
0.00%
-50.0%
Q3 2022$510,000
+16.7%
7,804
+8.5%
0.00%
+100.0%
Q2 2022$437,000
-27.4%
7,194
-24.9%
0.00%0.0%
Q1 2022$602,000
-26.3%
9,585
-11.1%
0.00%
-50.0%
Q4 2021$817,000
-55.2%
10,776
-33.8%
0.00%
-60.0%
Q3 2021$1,822,000
-17.3%
16,278
+19.6%
0.01%
-16.7%
Q2 2021$2,204,000
+73.5%
13,614
+30.7%
0.01%
+50.0%
Q1 2021$1,270,000
-23.9%
10,420
-4.4%
0.00%
-33.3%
Q4 2020$1,669,000
+76.4%
10,903
-3.6%
0.01%
+50.0%
Q3 2020$946,000
+31.9%
11,308
+16.0%
0.00%0.0%
Q2 2020$717,000
+106.0%
9,751
+19.0%
0.00%
+33.3%
Q1 2020$348,000
-55.6%
8,195
-36.3%
0.00%
-25.0%
Q4 2019$783,000
+29.0%
12,856
-13.1%
0.00%
+33.3%
Q3 2019$607,000
-16.5%
14,797
-4.2%
0.00%
-25.0%
Q2 2019$727,000
+14.7%
15,442
-13.1%
0.00%0.0%
Q1 2019$634,000
+25.5%
17,760
+0.5%
0.00%0.0%
Q4 2018$505,000
-41.3%
17,665
-9.0%
0.00%
-33.3%
Q3 2018$861,000
-26.1%
19,404
-2.1%
0.01%
-25.0%
Q2 2018$1,165,000
+19.7%
19,830
-6.8%
0.01%
+33.3%
Q1 2018$973,000
+87.5%
21,277
-3.7%
0.01%
+50.0%
Q4 2017$519,00022,1000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders